跳至主要内容
临床试验/NL-OMON41768
NL-OMON41768招募中不适用

Monitoring the intrahepatic immune responses in chronic HBV patients after long-term treatment with tenofovir - HBV-FNAB F

Stichting Maag-, Darm- en Leveronderzoek0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Chronic HBV patients who were included in the Tenofovir-FNAB study, and are currently still under treatment with tenofovir or became HBsAg-negative (HBsAg loss) in the meantime
  • * Signed informed consent

排除标准

  • * (Re-) infection with HIV, hepatitis B or C after the Tenofovir-FNAB study * Decompensatedcirrhosis (Child * Pugh Grade B or C) * Ultrasonic or other prove of hepatocellular
  • carcinoma or other carcinoma * Pregnant woman * Any other condition or
  • prescribed medication in which in the opinion of the investigator would make the
  • patient unsuitable for enrollment.

研究者

发起方
Stichting Maag-, Darm- en Leveronderzoek

相似试验